Priorityreviewvoucher
About Priorityreviewvoucher
Priorityreviewvoucher is a company was acquired by Biohaven Pharmaceutical in March 2019. Priorityreviewvoucher offers products and services including Priority Review Voucher Program.
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Biohaven Pharmaceutical
(Mar 18, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Priorityreviewvoucher
Priorityreviewvoucher offers a comprehensive portfolio of products and services, including Priority Review Voucher Program.
Incentive for faster FDA drug approvals
Funding Insights of Priorityreviewvoucher
Detailed funding history for Priorityreviewvoucher
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Priorityreviewvoucher
Priorityreviewvoucher has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Biohaven Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapies for neurological and neuropsychiatric diseases are developed.
|
Locked | Locked | Locked |
Investor details for Priorityreviewvoucher
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Priorityreviewvoucher
Investment portfolio details for Priorityreviewvoucher
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Priorityreviewvoucher
Detailed financials for Priorityreviewvoucher
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Priorityreviewvoucher Comparisons
Peer comparison for Priorityreviewvoucher
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Priorityreviewvoucher
Detailed competitors of Priorityreviewvoucher
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Priorityreviewvoucher
Complete news archive for Priorityreviewvoucher
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Priorityreviewvoucher
Priority review vouchers are issued by Priorityreviewvoucher to facilitate accelerated regulatory reviews of pharmaceutical products. Treatments for neglected diseases, rare pediatric conditions, or medical countermeasures qualify developers for these vouchers, which can be transferred or sold to hasten approvals for other drugs. The initiative encourages innovation in underserved areas while shortening market entry timelines for new therapies. Operations focus on the pharmaceutical sector, with no fixed expiration for the program.
Priorityreviewvoucher offers Priority Review Voucher Program.
Priorityreviewvoucher has 1 investor. Key investors include Biohaven Pharmaceutical.